Financial Consulate’s Viking Therapeutics VKTX Stock Holding History

Financial Consulate’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.2K	Buy	+98	New	+$3.4K	﹤0.01%	1002

Other funds holding VKTX

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return

Lewis Asset Management Lafayette, California $294M AUM 25.62% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

MN Wealth Advisors Overland Park, Kansas $247M AUM 16.11% 1-Year Est. Return

Royal Fund Management Lady Lake, Florida $1.26B AUM 23.83% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Financial Consulate's VKTX Position: Q3 2026 in Review

Financial Consulate opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 98 shares worth $3.2K. The stake represents ﹤0.01% of the portfolio and ranks #1002 among its holdings.

71 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

Financial Consulate held 98 shares of Viking Therapeutics worth $3.2K as of Q3 2026.
Viking Therapeutics was a new Financial Consulate position in Q3 2026.
Viking Therapeutics made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1002 holding.
71 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.